throbber
biogen idee
`
`April 20, 2007
`
`Center for Drug Evaluation and Research
`Food and Drug Administration
`5901 -B Ammendale Rd
`Beltsville, MD 20705-1 266
`
`Attn: Russell Katz, MD
`
`RE: IND 73,061: BG00012 (Dimethyl Fumarate): Multiple Sclerosis
`Submission of Clinical Trial Protocols
`Serial No.: 0017
`
`Dear Or. Katz:
`
`Reference is made to the End of Phase 2 meeting for Biogen Idee's product, BG00012
`(dimethyl fumarate) held on August 30, 2006. At this meeting, the Agency requested that
`Biogen Idee submit the final study report for an ongoing 11 -month chronic toxicology study in
`beagle dogs prior to the initiation of Phase 3 clinical trials.
`
`Following the meeting, Biogen Idee submitted two Phase 3 clinical trial protocols under the
`guidance of Special Protocol Assessment (Serial Nos. 012 and 013, dated 27 October 2006) to
`INO 73, 061 . At the Agency's request, both Phase 3 protocols were withdrawn from the INO
`(Serial No. 0 14, dated 08 December 2006) pending submission of the 11-month dog
`toxicology study.
`
`Although the protocols were withdrawn, the Agency provided written comments on both
`protocols (dated 11 and 12 December 2006).
`
`At this time, we are resubmitting the two Phase 3 protocols, revised to reflect Agency
`comments, and all supporting data. Specifically, the following documents are included in this
`submission:
`
`• Study P00012-05-05: "BG00012: An 11 Month Toxicity Study of BG00012
`Administered by the Oral (Capsule) Route to Dogs with a 1-Month Recovery
`Period"
`
`• Protocoi109-MS-301: "A Randomized, Multicenter, Double-Blind, Placebo(cid:173)
`Controlled, Dose-Comparison Study to Determine the Efficacy and Safety of
`BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis"
`
`• Protocoi109-MS·302: "A Randomized, Multicenter, Placebo-Controlled and
`Active (Giatiramer Acetate) Comparison Study to Evaluate the Efficacy and
`Safely of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis"
`
`Blogen Idee 14 Cambridge Cantor Camb<idgo, MA 02142 Phone 617 679 2000 www.biogcnidcc.com
`
`Page 1 of2
`
`Biogeo Exhibit 2285
`Coalition v. Biogeo
`IPR2015-01993
`
`

`
`biogen idee
`
`• Study 1 09-HV-1 01 : A Single-Center, Randomired, Blinded, Placebo- and
`Active-Controlled Study to Evaluate the QTc JnteNal Prolongation Potential of
`BG00012 When Administered to Healthy Volunteers"
`
`•
`
`Biogen Idee plans to initiate clinical trials sites in the United States in approximately 30 days of
`this submission. We would greatly appreciate any feedback the Agency may have on our two
`Phase 3 clinical trial protocols prior to initiation.
`
`Should you require any additional information, please contact Tammy Sarnelli. Associate
`Director, Regulatory Affairs at 617-679-3513. The contact for technical aspects for this
`submission is~. Senior Director, Regulatory Affairs Operationsat617-679-2416.
`
`Phone{617)679-3783
`
`Fax (617) 679-3170
`
`Biogen Idee 14 Camb",dgc Centc• Camonoge, MA 02142 f'rl0110 617 679 2000 www.b,ogemdec.r.om
`Page 2 of2

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket